|
Acrux Ltd - Comparative Business Analysis Snapshot
Business Description
Acrux Ltd. The Group's principal activities are developing and marketing healthcare products. It operates in the pharmaceutical research and development industry. Products include women's health products particularly those targeting the issues on menopausal symptoms, decreased libido in women and contraception; other transdermal delivery products used to address chronic pain, male testosterone deficiency, anxiety-related disorders, nausea, companion animal health and smoking cessation; and topical delivery products such as dermatology products. Brands include Estradiol MDTS, Testosterone MDTS, Nestorone MDTS, Fentanyl UDTS, Testosterone MD-Lotion, Buspirone MDTS, Granisetron MDTS, Nicotine MDTS and Skin and Nail. It operates in Australia, the United States of America and Europe.
Competitor Analysis
This analysis compares Acrux Ltd with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
